Professor
McGill University Health Centre (MUHC)/Royal Victoria Hospital
Clinical research
nonalcoholic fatty liver disease, HIV, HCV, liver fibrosis, non-invasive diagnostic tools in liver disease, biomarkers.

Giada Sebastiani is Professor of Medicine at McGill University and Clinician Scientist at the Research Institute of McGill University Health Centre in Montreal, Canada. She provides clinical services in the Division of Gastroenterology and Hepatology. She received a medical degree and specialized in internal medicine at the University of Padua, Italy. She had training in clinical and basic research at Harvard Medical School (US), University College of London (UK), University of Bordeaux (France) and Lady Davis Institute for Medical Research (Montreal, Canada). Her work focuses on fatty liver disease, liver fibrosis and non-invasive diagnostic tools in liver disease, with a current focus on at-risk populations, including people living with HIV, with type 2 diabetes, patients with inflammatory bowel diseases and women with polycystic ovary syndrome. She is author of 150 articles in peer-reviewed journals in the infectious diseases and hepatology fields (including Lancet Gastroenterology and Hepatology, Hepatology, Journal of Hepatology, Clinical Infectious Diseases, Journal of Infectious Diseases, AIDS; h-index=44, total number of citations>8,300), 15 book chapters, 250 conference publications at national and international congresses. She has been invited speaker in 70 international congresses and universities, including European, Asian Pacific, Mexican, Italian and Canadian Associations for the Study of the Liver. She was awarded the prestigious Clinical Research Salary Award Senior from Fonds Recherche Sante Quebec. Other honors include: honorary membership of the Romanian Association for the Study of the Liver; Emerging Stars in Hepatology Award (Asian Pacific Association for the Study of the Liver, 2010); Top 10 cited papers 2006-2008 Award by Journal of Hepatology - European Association for the Study of the Liver. She is funding and steering committee member of the Canadian NASH Network (https://cannash.ca) and the sole North American representative in the guidelines of the prestigious European AIDS Clinical Society. Her research program is funded by the Canadian Institute for Health Research, the Fonds Recherche Sante Quebec, the Canadian Donation and Transplantation Research Program, the CIHR Canadian HIV Trials Network, Crohn’s Colitis Canada.